Literature DB >> 16011830

The N588K-HERG K+ channel mutation in the 'short QT syndrome': mechanism of gain-in-function determined at 37 degrees C.

Mark J McPate1, Rona S Duncan, James T Milnes, Harry J Witchel, Jules C Hancox.   

Abstract

The idiopathic short QT syndrome (SQTS) is characterised by an abnormally short QT interval on the electrocardiogram and by an increased risk of arrhythmia and sudden death. One variant of the syndrome is linked to missense mutations that lead to a single amino-acid change (N588K; asparagine to lysine) in the S5-Pore linker region of the cardiac HERG K(+) channel. This study was performed in order to determine how the N588K mutation alters HERG channel current (I(HERG)) kinetics at mammalian physiological temperature. The whole-cell current-voltage (I-V) relation for wild-type (WT) I(HERG) measured from Chinese Hamster Ovary cells was maximal at approximately 0 mV and showed marked inward rectification positive to this. In contrast, N588K I(HERG) showed marked rectification only at +60 mV and at more positive voltages. The voltage dependence of activation of N588K-HERG did not differ significantly from that of WT-HERG. However, N588K I(HERG) had a significantly more positive inactivation V(0.5) (-8.14+/-0.82 mV) than did WT I(HERG) (-70.05+/-0.82 mV; P<0.001, unpaired t test; n=5 for each). Its P(Na)/P(K) ratio was also greater. The instantaneous I-V relation for N588K I(HERG) under action potential voltage clamp peaked at approximately +40 mV, compared to approximately -37 mV for WT-I(HERG). These findings underscore the importance of the S5-P linker in HERG channel function and indicate that N588K-HERG contributes increased repolarising current earlier in the ventricular action potential at physiological temperature due to a approximately +60 mV shift in voltage dependence of I(HERG) inactivation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16011830     DOI: 10.1016/j.bbrc.2005.06.112

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  47 in total

Review 1.  Computational modeling of the human atrial anatomy and electrophysiology.

Authors:  Olaf Dössel; Martin W Krueger; Frank M Weber; Mathias Wilhelms; Gunnar Seemann
Journal:  Med Biol Eng Comput       Date:  2012-06-21       Impact factor: 2.602

2.  High potency inhibition of hERG potassium channels by the sodium-calcium exchange inhibitor KB-R7943.

Authors:  Hongwei Cheng; Yihong Zhang; Chunyun Du; Christopher E Dempsey; Jules C Hancox
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs.

Authors:  M J McPate; R S Duncan; J C Hancox; H J Witchel
Journal:  Br J Pharmacol       Date:  2008-08-25       Impact factor: 8.739

4.  Role of intracellular domains in the function of the herg potassium channel.

Authors:  Moza Al-Owais; Kate Bracey; Dennis Wray
Journal:  Eur Biophys J       Date:  2009-01-27       Impact factor: 1.733

Review 5.  Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.

Authors:  Rashmi R Shah
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

6.  The G604S-hERG mutation alters the biophysical properties and exerts a dominant-negative effect on expression of hERG channels in HEK293 cells.

Authors:  Jianhua Huo; Yanmin Zhang; Na Huang; Ping Liu; Chen Huang; Xueyan Guo; Wenhui Jiang; Nan Zhou; Andrew Grace; Christopher L H Huang; Aiqun Ma
Journal:  Pflugers Arch       Date:  2008-04-03       Impact factor: 3.657

Review 7.  Purkinje physiology and pathophysiology.

Authors:  Penelope A Boyden
Journal:  J Interv Card Electrophysiol       Date:  2018-07-28       Impact factor: 1.900

Review 8.  Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.

Authors:  William T Harkcom; Geoffrey W Abbott
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-08

9.  Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome.

Authors:  Aziza El Harchi; Mark J McPate; Yi hong Zhang; Henggui Zhang; Jules C Hancox
Journal:  J Mol Cell Cardiol       Date:  2009-03-10       Impact factor: 5.000

10.  hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome.

Authors:  M J McPate; H Zhang; J M Cordeiro; C E Dempsey; H J Witchel; J C Hancox
Journal:  Biochem Biophys Res Commun       Date:  2009-06-06       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.